[Experimental study of anti-radiation effects of interleukin-1 beta].
Therapeutical effect of human recombinant IL-1 beta on exposed CBA mice was shown. Single injection of IL-1 beta into mice exposed to LD70, LD80 and LD100 raised their 30-day survival by 60, 40 and 35%, respectively. Therapeutically effective doses of IL-1 beta were 100-200 micrograms/kg. Multiple injections of the preparation were ineffective.